New federal initiatives are expanding the options available to healthcare providers for voluntarily disclosing potential fraud.
McCarter partner Khaled Klele spoke with Part B News about a new Healthcare False Claims Act Self-Disclosure Pilot Program developed by the Department of Justice (DOJ) and the Department of Health and Human Services (HHS).
The six-month pilot program, which runs through April 22, 2027, offers participating healthcare entities potential benefits including reduced repayment multipliers and exemptions from Corporate Integrity Agreements, Civil Monetary Penalties, and Medicare enrollment revocation.
Kay noted that the Medicare enrollment revocation provision is significant because HHS recently gave DOJ revocation authority that had previously been reserved for the Office of Inspector General. Under the new pilot, the Centers for Medicare & Medicaid Services (CMS) will not impose civil monetary penalties or seek Medicare enrollment revocation as part of a resolution.
This article is from Part B News.
